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Abstract  
Background: Survivors of intensive care units (ICUs) commonly present with symptoms of 
anxiety, depression and post-traumatic stress disorder (PTSD) during recovery. A number of 
factors have been identified as predictors of these adverse emotional outcomes, but the role of 
state anxiety during critical illness in the development of these emotional problems remains 
unknown.  
Purpose: The ICARe (Intensive Care Anxiety and Emotional Recovery) study protocol propose 
the development of an statistical model to determine the relationship between state anxiety 
during ICU stay and symptoms of anxiety, depression and PTSD at three occasions; after ICU 
discharge but prior to hospital discharge and at the third and sixth months post ICU discharge.  
Methods: Prospective study including adult patients admitted to the ICU of a tertiary metropolitan 
Australian hospital for ≥ 24 hours who are able to: (1) communicate verbally or nonverbally; (2) 
understand English and (3) open their eyes spontaneously or in response to voice to respond to 
the Faces Anxiety Scale (state anxiety assessment). One hundred and seventy patients will be 
assessed for their levels of state anxiety during their ICU stay to achieve a sample size of about 
104 patients prior to hospital discharge. The outcomes of the ICARe study will include symptoms 
of anxiety, depression and PTSD assessed by standardised and well validated questionnaires 
widely used in intensive care research. Demographic, clinical, and social support information will 
also be collected. 
Results: The projected sample size will provide sufficient power to evaluate the association 
between state anxiety and adverse emotional outcomes, as well as a variety of variables that will 
be entered into a multivariate regression analysis. 
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Conclusion: This study will provide new evidence to improve care during critical illness and 
reduce adverse outcomes during recovery with the potential to decrease unnecessary suffering, 
promote comfort and improve long-term recovery. 
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Introduction 
Advances in research, technology and expert care have permitted continuous improvements in 
the survival of intensive care patients. However, these survivors commonly present with 
symptoms of anxiety, depression and post-traumatic stress disorder (PTSD) during recovery. 
Systematic reviews including studies of survivors of the ICU; mainly from developed countries 
such as the United Kingdom (UK), United States of America (USA), Australia and some 
European countries, have reported that the prevalence of these emotional problems in the ICU 
population is relatively high (1-3). When looking at the literature as a whole, it can be observed 
that approximately 25% of ICU survivors experience some emotional problem, either symptoms 
of anxiety, depression or PTSD. Further, it has been suggested that these emotional problems 
after the ICU experience may negatively affect these survivors’ health-related quality of life 
(HRQoL) (4-9). 
A number of factors have been identified as predictors of these adverse emotional outcomes in 
ICU survivors (7, 9-19). In the Intensive Care Anxiety and Emotional Recovery (ICARe) study, 
these risk factors have been classified into three categories: prior to critical illness, during 
intensive care treatment and after ICU discharge risk factors (Fig.1). Prior to critical illness risk 
factors include demographic characteristics such as female gender and younger age, low level 
of education, history of smoking and alcohol dependence, mental health history (premorbid 
anxiety, depression and psychiatric illness) and personality trait of pessimism. During intensive 
care risk factors include sedation, duration of mechanical ventilation, length of ICU stay and 
neurobiological factors such as hypoxaemia, hypoglycaemia and neuroendocrine dysregulation; 
and after ICU risk factors include memories of the ICU, neurocognitive impairment and lack of 
social support. The presence of state anxiety during ICU stay has been identified as a frequent 
and serious problem for critically ill patients, which could be another possible during intensive 
care treatment factor, related to adverse emotional outcomes, however, the relationship 
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between this emotion during critical illness and adverse emotional outcomes remains unknown 
(20).  
Anxiety was conceptualised as state anxiety and trait anxiety by Spielberger in the sixties (21). 
This distinction has provided a better understanding of this complex phenomenon and this 
approach has been recognised in much literature and research. State anxiety is defined as a 
normal and temporary emotion that involves physiological arousal and feelings of tension, 
apprehension, nervousness and worry when a stressful situation is perceived. Trait anxiety, on 
the other hand, corresponds to the person's tendency to become state anxious as part of their 
personality trait (22). Because critically ill patients are constantly exposed to a great variety of 
stressors while receiving intensive care treatment, state anxiety is highly prevalent in the ICU 
population, especially in those requiring mechanical ventilation (23).  In Australia, for example, 
an investigation including 106 ICU patients found some level of anxiety in 85% of them (24). The 
level of anxiety reported was moderate to severe despite receiving sedation and/or analgesia 
(24). 
In addition, it is known that anxiety during critical illness is either poorly assessed or not 
assessed at all because of the challenge implied in assessing a self-report symptom in patients 
with inability to verbalise their feelings due to endotracheal intubation and mechanical 
ventilation. Thus, clinicians often identify state anxiety by observation of behavioral (e.g. 
restlessness) and physiological (e.g. tachycardia) manifestations (24, 25). Unfortunately, 
clinicians’ observations of these two components are unreliable indicators of state anxiety in ICU 
settings since common conditions such as delirium or pain share similar physiological and 
behavioural characteristics with this emotion which may lead  to erroneous  symptom 
interpretation (25). Moreover, it has been found that state anxiety may not always be 
accompanied by physiological changes (24, 26, 27).   
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Another factor that has made the assessment difficult is the lack of appropriate instruments to 
assess state anxiety in ICU patients. Only recently, specially designed tools for the assessment 
of this emotion in seriously ill patients have been available, although the use of these has not yet 
been included in routine clinical practice (24, 27-29). This study protocol proposes the 
development of a statistical model in order to acquire a better understanding about the 
relationship between state anxiety during the ICU stay and short and medium-term emotional 
outcomes in survivors of the ICU as well as the association between the levels of state anxiety 
and sedation/analgesia during the intensive care treatment. 
Methods 
Aims 
This study aims to determine the association between state anxiety during the ICU stay and 
symptom of anxiety, depression and PTSD at three occasions in survivors of the ICU; after ICU 
discharge but prior to hospital discharge and at the third and sixth months after ICU discharge. It 
also aims to examine the relationship between state anxiety and sedation/analgesia for ICU 
patients during the intensive care treatment.  
Design 
This research is a prospective longitudinal cohort study of ICU survivors. This observational 
design will allow studying state anxiety during the ICU stay as an intra-ICU risk factor for the 
subsequent development of adverse emotional outcomes during recovery. In addition, it will also 
allow follow up of the patients at three occasions to determine the short and medium-term 
effects of state anxiety on emotional recovery. 
Setting 
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This study will be conducted in the adult ICU of a tertiary metropolitan hospital located in 
Brisbane, Queensland, Australia. This ICU has 25 beds, including general ICU patients and 
post-cardiac surgery patients. The nurse/patient ratio is 1:1 and in 2009/2010, there were 
approximately 2000 admissions to this ICU. 
Sample 
All adult patients (≥ 18 years of age) admitted to the ICU for ≥ 24hours, who are able to: (1) 
communicate verbally or non-verbally; (2) understand English; and, (3) open their eyes 
spontaneously or in response to voice to respond to the Faces Anxiety Scale (FAS) will be 
invited to participate in this study.  
Sample size 
In this study, previous research exploring similar research question in the ICU population has 
been examined to determine the effect size reported and perform power analysis a priori using 
G*Power 3.1.3 (30). The effect size reported in the literature testing correlations in the ICU 
context is often medium (1-3). Therefore, a medium effect size and a selected power of 80% 
with a significance of α = 0.05 have been used to estimate the sample size for this study.  
In addition, the variables that are significant at a 0.1 level will be entered into a multivariate 
regression analysis. The number of predictors that will be entered into this model is unknown at 
this stage, but based on the number of prior to critical illness, during intensive care treatment 
and after ICU discharge variables that will be controlled for; the number of predictors is expected 
to be seven. By convention, a moderate effect size for multiple regression is R² = 0.13, 
therefore, using power of 80% and α = 0.05, the number of participants needed is 104 (31, 32).  
Because longitudinal research in the ICU population often reports a number of patients lost to 
follow up, 170 patients will be assessed for state anxiety during their ICU stay to obtain a sample 
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of about 104 patients prior to hospital discharge. We have estimated 70% completion of follow 
up prior to hospital discharge and an in-hospital mortality rate of 10%.  
Recruitment process 
All ICU patients will be screened daily by the principal investigator for potential enrolment, with 
liaison with the ICU Research Nurse to determine eligibility. Each participant will be approached 
at an appropriate time determined in consultation with the bed-side ICU nurse. Patients’ assent 
will be required to include patients in this study during the ICU stay, and then when the patients 
are in the wards (after the ICU stay but prior to hospital discharge), written consent will be 
requested. This process has been approved by the relevant Human Research Ethics 
Committees. 
Data collection  
Data regarding prior to critical illness, during intensive care treatment and after ICU discharge 
variables will be collected in order to control for confounding variables when testing the 
association between state anxiety and adverse emotional outcomes. All the data needed for this 
study will be collected within nine months from the commencement of this study, at four 
occasions; (1) during the ICU stay, (2) after the ICU stay but prior to hospital discharge, (3) at 
the third and (4) sixth months after hospital discharge.  
During the patients’ ICU stay, the levels of state anxiety will be assessed according to a protocol, 
and clinical and demographic data will be collected from medical records. Data regarding 
adverse emotional outcomes and some confounding variables such as memories of the ICU, 
cognitive functioning, personality trait of optimism versus pessimism, personality trait of anxiety, 
smoking and alcohol consumption and social support will be assessed using standardised 
questionnaires. These questionnaires will be administered after the ICU stay but prior to hospital 
discharge and at the third and sixth month after ICU discharge. The questionnaires will contain 
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approximately 67 items, and will be given to the patient with a covering letter providing 
instructions for participants to complete the questionnaires within the next days at a time 
convenient to them, but without assistance from family members/friends. At the third and sixth 
months post ICU discharge, the same questionnaires, with the exception of personality trait of 
optimism versus pessimism and personality trait of anxiety, will be posted to the participants’ 
address. An appointment for a phone interview will be scheduled so participants can read their 
answers to the researcher. Alternatively, a reply paid envelope will be provided. The researcher 
will contact the participant or next of kin to confirm that the participants are alive before posting 
all the questionnaires.  
Mortality during the ICU stay, at the third month and sixth month after ICU discharge will be 
recorded. Follow-up at the three occasions proposed in this study will enable the assessment of 
the impact of state anxiety during the ICU stay on medium and long-term emotional recovery 
and fluctuations of this relationship over time.  
Variables 
Prior to critical illness, during intensive care treatment and after ICU discharge variables, the 
relevant measure and the time point for assessment are summarised in tables 1 and 2. The 
assessment of state anxiety will be explained in more detail since this is the primary predictive 
variable of interest in this study. 
State anxiety assessment tool  
Self- reported levels of state anxiety during the ICU stay will be assessed by the Faces Anxiety 
Scale (FAS) (24). The FAS is a single-item instrument especially designed to measure state 
anxiety in ICU settings. It consists of a scale showing five faces representing five different levels 
of anxiety, ranging from no anxiety to extreme anxiety, scoring from one to five. The patient is 
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asked how much anxiety is felt at the moment of assessment and the answer may by a verbal or 
a nonverbal response, i.e. they can point to the relevant face. The reported criterion validity of 
this tool was 0.64 (P < 0.001) in mechanically ventilated patient (correlation between the self-
report of anxiety on the FAS and clinical judgment of anxiety) (24). While its reliability has not 
been measured because of limitations in reliability methods for a single-item instrument (24, 33), 
the FAS is a practical tool to assess this emotion in critically ill patients. 
State anxiety assessment protocol 
After screening for eligible participants with the ICU research nurse, the researcher and the bed-
side nurse will discuss and plan the best time for the assessment. State anxiety will be assessed 
twice daily (morning 8-11am and evening 4-7pm). The time to perform this assessment is 
approximately one minute and does not involve any invasive procedure. After the bed-side nurse 
agrees, the researcher will observe and record the airway status (tracheostomy, endotracheal 
tube), mechanical ventilation status (invasive, non-invasive, non-ventilation), delirium status (The 
Confusion Assessment Method for the ICU), oxygen saturation, pain score (Verbal Pain Scale 
and/or The Critical Care Pain Observation Tool) and main sedation administration method 
(continuous infusion, intermittent, daily sedative interruption). Then, the researcher will approach 
the patient and explain the procedure. The patient will be shown the Faces Anxiety Scale (FAS) 
with the following instructions:  
• These faces are showing different levels of anxiety.  
• This face shows no anxiety at all; this face shows a little bit more; a bit more (sweep 
finger along scale); right up to extreme anxiety.  
• Have a look at these faces and choose the one that shows how much anxiety you feel at 
the moment (34).  
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The level of state anxiety will be measured as a continuous variable (scale from 1 to 5 points), 
and then the value obtained will be categorised into, low (1 -2) or moderate to severe anxiety 
(score 3-5) for analysis, consistent with instructions provided by the scale developer. 
Adverse Emotional Outcomes 
The adverse emotional outcomes assessed in this study include symptoms of anxiety, 
depression and PTSD measured at three occasions, after ICU discharge but before hospital 
discharge, at the third and sixth month after ICU discharge. These outcomes will be assessed by 
standardised self-report measures, widely used in ICU research.  
Symptoms of anxiety and depression will be measured by the Hospital Anxiety Depression Scale 
(HADS) (35). This self-report questionnaire consists in 14 statements divided into two seven-
statement subscales, one for depression and one for anxiety. Each statement has four possible 
alternatives (0-3) indicating the frequency of the feeling assessed. Only one alternative is 
chosen for each statement. Three scoring ranges for each subscale are possible: normal (0-7), 
borderline abnormal (8-10, suggesting possible psychological distress) and abnormal (11-21, 
suggesting probable psychological distress). Symptoms of anxiety and depression will be 
classified into the three categories of the HADS recommended in Zigmond&Snaith (1983). 
These categories are normal (score 0-7), possible case (score 8-10) and probably case (score 
11-21). The HADS assesses symptoms of anxiety and depression in hospital settings, and it is 
commonly used as an instrument to measure these adverse emotional outcomes in critical care 
research (36-39).  
Symptoms of post-traumatic stress disorder will be measured by the Post-Traumatic Stress 
Syndrome 10-Questions Inventory (PTSS-10) (40). This is a self-report two-part questionnaire 
(part A and part B) designed to screen for PTSD symptoms in survivors of critical illness.  Part A 
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consists in a statement about the patients’ memory of their ICU admission.  Two alternatives 
(Yes/ No) are possible to indicate the presence or absence of four traumatic memories. These 
memories are memories of nightmares; severe anxiety or panic; severe pain; and, respiratory 
distress. In part B, the presence and intensity of 10 PTSD symptoms are assessed. These 
symptoms are sleeping disturbance, nightmares, depression, hyperalertness, emotional 
numbing, irritability, labile mood, guilt, avoidance of activities prompting recall of the traumatising 
event, and muscular tension. Each symptom can be rated from 1 (never) to 7 (always); 
therefore, a total score ranging from 10 to 70 points can be obtained. Symptoms of PTSD will be 
classified according the recommended cut-off of 35 points (scale from 10 to 70 points) into two 
categories, high probability of PTSD (total score > 35 points) and low probability of PTSD (< 35 
points) (40). 
Planned analyses 
The Statistical Package for the Social Sciences version 20.0 (SPSS IBM Corp. in Armonk, NY) 
will be used to analyse the data. Once the data have been entered into SPSS, all variables will 
be cleaned and checked for missing and invalid values. Following data cleaning a 15% random 
sample of the database will be verified against original questionnaires (this will be conducted for 
all data collection points). Descriptions of categorical variables will be presented as numbers and 
percentages. Continuous data will be presented as a mean (±SD) or median with interquartile 
range. Appropriate statistical tests will be used to test bivariate relationships between the 
dependent variables and the independent variables. Continuous/Interval variables will be tested 
to confirm normality distribution before deciding on either parametric analysis (independent t-
test, one-way ANOVA, Pearson’s r) and/or non-parametric analysis (Mann-Whitney U, Kruskal 
Wallis & Spearman’s). Chi-square tests will be performed for categorical data.  When 
considering the analysis of longitudinal data, appropriate repeated measures analyses will be 
employed. Variables associated with p < 0.10 on bivariate analysis will be included in the final 
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models to identify which factors are independently associated with adverse emotional outcomes 
(symptoms of anxiety, depression and PTSD). A stepwise process will be used during the model 
building, where variables not reaching a significance level p < 0.05 will be omitted.  Modelling of 
longitudinal data will involve mixed effects analysis of emotional outcomes over time.    
Ethical Considerations 
This study has been approved by the Hospital and Griffith University Human Research Ethics 
Committees. Verbal or nonverbal assent will be sought from each patient during the ICU stay 
prior to collection of data. Then, when the patients are in the wards, written informed consent will 
be sought from each patient. Patients, who do not give consent, will be asked permission to use 
the ICU based-data. If permission to use this information is not given, the data will be destroyed. 
All data will be stored in locked facilities, with identifying and contact details stored separately to 
study data. Publications and presentations will be prepared in such a manner as to maintain the 
confidentiality and anonymity of all study participants. In this study, the general values and 
principles set out in the National Statement on Ethical Conduct in Human Research will be 
applied (41).  
Results and discussion 
The ICARe study is a single-center prospective longitudinal study that intends to address the 
issue of adverse emotional outcomes in survivors of the ICU. Whereas previous studies have 
measured short, medium and long-term emotional outcomes and identified factors that may lead 
to the development of anxiety, depression and PTSD in ICU survivors, the impact of the amount 
of state anxiety that patients feel during the ICU stay on emotional recovery remains unclear.  
To date, there is enough evidence to propose an existing relationship between state anxiety 
during the ICU stay and adverse emotional outcomes during recovery. Patients who present with 
moderate to severe levels of state anxiety during critical illness may be at a higher risk for 
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developing symptoms of anxiety, depression and PTSD during recovery than those with low or 
no anxiety. This relationship may be through a direct link and/or an indirect link involving 
sedation. As the emotional component of state anxiety is poorly assessed during critical illness, 
state anxiety might not be detected in a timely manner and, therefore, remain unrelieved for long 
periods of time. This situation may have a direct impact on the development of adverse 
emotional outcomes in the longer term. On the other hand, if anxiety progresses to extreme 
levels and patients exhibit psychomotor agitation, the use of increased doses of sedative agents 
may be given. Thus, sedation could represent an indirect link to adverse emotional outcomes 
after the ICU experience.  
The significance of this study can be considered from a number of viewpoints. The first aspect 
concerns ICU survivors and their families. For many patients, the presence of these emotional 
consequences can  impact their quality of life, affecting for example, their family and social 
relationships; employment and economic status; and physical recovery.  
The second aspect relates to health care professionals. State anxiety is widely acknowledged as 
a serious problem in ICU settings despite current ICU management. However, the lack of 
evidence-based knowledge on the consequences that this emotion may have on the short, 
medium and long-term emotional recovery of patients, may lead clinicians to disregard the 
assessment and management of this emotion during ICU treatment. The ICARe study seeks to 
understand this association and inform clinicians about the short and medium-term effects of 
state anxiety on emotional recovery, so as to facilitate change in clinical practice and improve 
outcomes for ICU survivors.  
The third aspect pertains to the efficient use of health care resources. Systematic reviews, with 
an international viewpoint, have estimated that approximately a quarter of the patients who 
survive the intensive care treatment develop emotional problems, which may endure for years 
(1-3). The emotional recovery of these patients involves health care resources, expenses that 
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could be avoided by preventing these emotional consequences. Considering that annually 
millions of patients are admitted to ICUs around the world, this situation is, undoubtedly, an 
important public health issue. Ultimately, the findings of this study will generate new evidence to 
inform future research and clinical practice.  
The strength of the ICARe study is that a comprehensive assessment of the most relevant prior 
to critical illness, during intensive care treatment and after ICU discharge factors described in the 
literature will be conducted. This strength will permit the development of a conceptual model 
where the significance of the relationships between risk factors and adverse emotional 
outcomes will be identified. In addition, the direction of these associations will be determined. 
The ICARe study proposal has some constraints. State anxiety will be assessed after 24 hours 
of ICU admission, twice daily during the patients’ ICU stay. Therefore, it is possible that, despite 
frequent data collection, the ICARe study may not fully capture the variations of the levels of 
anxiety within a 24 hour period. The levels of state anxiety may vary over time in a dynamic 
environment such as the ICU. Nevertheless, this emotion could only be assessed twice daily due 
to the burden associated with the data collection process. Although the design of the ICARe 
study includes a comprehensive collection of prior to critical illness, during intensive care 
treatment and after ICU discharge variables that will take into account confounding variables 
and bias, so that the effects of state anxiety on adverse emotional outcomes can be determined, 
some key risk factors for the development of these adverse emotional outcomes may still be 
unknown or unmeasured in this study.  
Conclusion 
The ICARe study is a prospective longitudinal study of survivors of ICU treatment six months 
after discharge. This study aims to provide new knowledge about the association between state 
anxiety during the ICU stay and the development of symptoms of anxiety, depression and PTSD 
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during recovery. The strengths of the study include comprehensive measurement of prior to 
critical illness, during intensive care treatment and after ICU discharge risk factors  for the 
development of relevant adverse emotional outcomes; an adequate sample size, determined by 
power analysis; and the development of a statistical model. This research has the potential to 
inform the development of interventions designed to improve the emotional outcomes of patients 
being admitted to intensive care units by describing factors that affect their recovery. Improved 
emotional recovery may result in reduced burden for patients, their families and the health care 
system.  
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Table 1: study constructs, measures, number of items and data collection schedule  
Measure  Outcomes ICU After ICU, but prior to 
hospital discharge 
3
rd.
 mo. 6
th.
 mo. 
HADS  Symptoms of anxiety  7 7 7 
HADS Symptoms of depression  7 7 7 
Part B of PTSS-10  Symptoms of PTSD    10 10 
Measure  Variables        
FAS State anxiety 1    
Part A PTSS-10 Memory    1 1 1 
LOT-R Trait pessimism   6     
STAI Form Y-2 Trait anxiety   20     
MSPSS Social support   12  12 12 
MOS COG-R Cognitive function   6 6 6 
QF method Smoking  2 2 2 
GQF method Alcohol consumption  2 2 2 
Patient 
demographics 
questionnaire 
Level of education  1   
Employment status  1 1 1 
Mental health history   1   
Pre-ICU medications 
(steroids, opioids, benzos, 
beta-blockers, anxiolytics) 
 1   
Total No of Items   1 67 48 48 
HADS: Hospital Anxiety Depression Scale; PTSS-10: Post-Traumatic Stress Syndrome 10-Questions 
Inventory; PTSD: Post-traumatic Stress Disorder; FAS: Faces Anxiety Scale; LOT-R: Revised Life 
Orientation Test; STAI Form Y-2: State Trait-Anxiety Inventory Form Y-2; MSPSS: The Multidimensional 
Scale of Social Support; MOS COG-R: Medical Outcomes Study Cognitive Functioning Scale-Revised; 
QF method: Quantity Frequency method; GQF method: Graduated Quantity Frequency method; APACHE 
III: Acute Physiology and Chronic Health Evaluation III.  
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Table 2: clinical and demographic data, collected from medical records during the ICU 
stay 
Gender & age  
Airway status (tracheostomy, endotracheal intubation) 
Hypoxaemia (oxygen saturation) 
Diagnosis ICU admission  
Severity of illness: Acute Physiology and Chronic Health Evaluation III (APACHE III) 
Delirium 
Length of mechanical ventilation, ICU & hospital stay 
MV status (invasive, non-invasive, non-ventilation) 
Sedation administration method (continuous, intermittent, daily sedative interruption) 
Duration of sedation & total doses of sedatives, opioids, steroids and anxiolytics 
 
 
 

